已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Emodin promotes GSK-3β-mediated PD-L1 proteasomal degradation and enhances anti-tumor immunity in hepatocellular carcinoma

大黄素 肝细胞癌 癌症研究 免疫 免疫系统 降级(电信) 医学 化学 内科学 免疫学 生物化学 计算机科学 电信
作者
Xuemei Yang,Weiguang Chen,Haitao Sun,Weicong Chen,Wei Xu,Chunyu He,Yang Liu,Ying Kuang,Yuanfang Ma,Bing-Lian Zhong,Chaojie Li,Guohuan Li,Qingfeng Du,Songqi He
出处
期刊:Chinese Medicine [BioMed Central]
卷期号:20 (1)
标识
DOI:10.1186/s13020-025-01146-6
摘要

Abstract Background Programmed death-ligand 1 (PD-L1), a prominent immune checkpoint, interacts with programmed death protein-1 (PD-1) on cytotoxic T cells within tumors and promotes immune evasion. Emodin, which is known to destabilize PD-L1 in breast cancer, has great potential for enhancing anti-tumor immunity. However, whether emodin can modulate PD-L1 levels in hepatocellular carcinoma (HCC) and enhance anti-tumor immune response remains unclear. Materials and methods PD-L1 levels were assessed by western blot and RT-qPCR, the degradation mechanism was analyzed using specific inhibitors. Network pharmacology, molecular docking, and glycogen synthase kinase-3 beta (GSK-3β) modulation analyzes were performed to validate emodin’s target. In vivo anti-tumor effects were evaluated in H 22 subcutaneous tumor model, and CD8 + T cells and RNA-seq data were analyzed. The synergistic effects of emodin and an anti-PD-L1 antibody were assessed. Results Emodin effectively reduced PD-L1 levels in H 22 cells and increased anti-tumor activity in an H 22 subcutaneous tumor model by promoting CD8 + T cells infiltration and TNF-α, IFN-γ, and granzyme B secretion. Mechanistically, emodin accelerated PD-L1 degradation through the proteasome pathway in both mouse and human HCC cell lines, as confirmed by the use of proteasome, lysosome and autophagy inhibitors. Network pharmacology analysis and molecular docking revealed that GSK-3β, a key regulator of PD-L1 degradation, is a target of emodin. Selective inhibitor-mediated suppression of GSK-3β largely reversed the regulatory effect of emodin on PD-L1. In contrast, overexpression of GSK-3β with a plasmid decreased PD-L1 protein levels and augmented emodin’s effect on PD-L1. Additionally, RNA-sequencing revealed the role of emodin in improving the immune responses in the tumor microenvironment. Finally, we observed a synergistic effect when the H 22 cell subcutaneous tumor model was treated with emodin and anti-PD-L1 antibody. Conclusion Emodin exerts anti-tumor effects by promoting GSK-3β-mediated PD-L1 proteasomal degradation and enhancing the anti-tumor effects of CD8 + T cells, indicating that emodin may be a promising therapeutic option for HCC. Graphical Abstract
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
qq发布了新的文献求助10
1秒前
水晶鞋完成签到 ,获得积分10
1秒前
7秒前
兽王打的面包完成签到,获得积分20
7秒前
12秒前
dbq完成签到 ,获得积分10
12秒前
乐羽乐完成签到,获得积分10
12秒前
zzzzzz完成签到 ,获得积分10
12秒前
第二支羽毛完成签到,获得积分10
14秒前
个性乐儿完成签到,获得积分10
14秒前
顾矜的应助被nnn采纳,获得10
15秒前
小田完成签到 ,获得积分10
16秒前
秋风的应助被yang采纳,获得10
16秒前
leotao完成签到,获得积分10
16秒前
16秒前
田様的应助被再吃亿大口采纳,获得10
17秒前
jianglai发布了新的文献求助200
17秒前
qq发布了新的文献求助10
17秒前
AdamJie发布了新的文献求助30
19秒前
MX完成签到 ,获得积分10
19秒前
成就马里奥完成签到,获得积分10
19秒前
19秒前
香蕉觅云的应助被Phoebe采纳,获得10
20秒前
嘻嘻哈哈的应助被谨慎的寄云采纳,获得10
20秒前
21秒前
浪迹发布了新的文献求助30
21秒前
深情安青的应助被英俊h采纳,获得10
22秒前
llx666完成签到,获得积分10
23秒前
chiaoyin999发布了新的文献求助10
23秒前
Pia完成签到 ,获得积分10
24秒前
bm发布了新的文献求助10
24秒前
24秒前
26秒前
小鱼发布了新的文献求助10
26秒前
平常的人雄完成签到,获得积分10
27秒前
27秒前
27秒前
Drwang完成签到,获得积分10
28秒前
火山口发布了新的文献求助10
28秒前
28秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184867
求助须知:如何正确求助?哪些是违规求助? 9573803
关于积分的说明 21833148
捐赠科研通 7782177
什么是DOI,文献DOI怎么找? 3434414
关于科研通互助平台的介绍 2558563
邀请新用户注册赠送积分活动 2481067